BIOVICA Aktie

>BIOVICA Performance

1 Woche: -21,1%

1 Monat: -40,0%

3 Monate: +150,0%

6 Monate: -88,3%

1 Jahr: -95,7%

laufendes Jahr: +150,0%

>BIOVICA Aktie

Name:

BIOVICA INTL. SK-,07

Land:

Schweden

Sektor:

Gesundheit

ISIN/ Wkn:

SE0008613731 / A2DPS4

Symbol/ Ticker:

9II (Frankfurt)

Kürzel:

FRA:9II, ETR:9II, 9II:GR

Index:

Webseite:

https://biovica.com/

Profil:

Biovica International AB, a key player in the biotechnology industry, specializes in the development and commercialization of diagnostic solutions that aim to enhance cancer treatment. The company's primary product, DiviTum, provides a revolutionary ..
>Volltext..

Marktkapitalisierung:

9.61 Mio. EUR

Unternehmenswert:

1.74 Mio. EUR

Umsatz:

1.06 Mio. EUR

EBITDA:

-6.2 Mio. EUR

Nettogewinn:

-6.93 Mio. EUR

Gewinn je Aktie:

-0.04 EUR

Schulden:

0.47 Mio. EUR

Liquide Mittel:

8.54 Mio. EUR

Operativer Cashflow:

-6.26 Mio. EUR

Bargeldquote:

4.96

Umsatzwachstum:

45.03%

Gewinnwachstum:

26.77%

Dividende je Aktie:

Dividendenrendite:

Dividendenschätzung:

Insiderhandel:

Suchwörter:

BIOVICA

Letzte Datenerhebung:

05.04.26

>BIOVICA Kennzahlen

Aktien/ Unternehmen:

Aktien: 277.49 Mio. St.

Frei handelbar: 95.98%

Leerverk. Aktien: -

Rückkaufquote: -114.28%

Mitarbeiter: 26

Umsatz/Mitarb.: 0.03 Mio. EUR

Analysten:

Analystenrating: No rating

Kursziel: 87.41%

Bewertung:

KGV: -

KGV lG: -

KUV: 17.29

KBV: 1.01

PEG-Ratio: -

EV/EBITDA: -

Rentabilität:

Bruttomarge: -664.65%

Gewinnmarge: -656.19%

Operative Marge: -664.65%

Managementeffizenz:

Gesamtkaprendite: -67.01%

Eigenkaprendite: -83.92%

>BIOVICA Peer Group

Gesundheit, Onkologie/ Krebs- Behandlung

>BIOVICA Chart & Kurs - Stuttgart

>BIOVICA News

09.03.26 - 17:18	Nomination Committee for Biovica International AB for the 2026 Annual General Meeting (Accesswire)
	UPPSALA, SE / ACCESS Newswire / March 9, 2026 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) - The Nomination Committee prior to the 2026 Annual General Meeting will consist of four ......

05.03.26 - 15:54	Biovica International: Biovica Announces Planned CEO Succession; Anders Rylander to Step Down During 2026 (Accesswire)
	UPPSALA, SWEDEN / ACCESS Newswire / March 5, 2026 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) - The Board of Directors of Biovica International AB today announces that Chief Execu......

12.02.26 - 09:06	Biovica International: Newly Published Data Reinforce Robust Prognostic Associations for DiviTum TKa in Metastatic Breast Cancer (Accesswire)
	UPPSALA, SE / ACCESS Newswire / February 12, 2026 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) - Biovica, a leader in blood-based cancer monitoring, today announces that results fr......

27.01.26 - 08:54	Biovica International: Strong DiviTum TKa Results Published in JCO Precision Oncology (Accesswire)
	UPPSALA, SE / ACCESS Newswire / January 27, 2026 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II), a leader in blood-based cancer monitoring, today announced that DiviTum TKa data from......

18.12.25 - 09:12	Biovica International AB - Q2 Interim report Aug - Oct 2025 (Accesswire)
	UPPSALA, SE / ACCESS Newswire / December 18, 2025 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) - Positioned for growth in Pharma Services and in the USAQ2 (August- October 2025) (c......

15.12.25 - 09:03	Biovica International: Biovica Signs Client Bill Agreement with Leading U.S. NCI-Designated Cancer Center (Accesswire)
	UPPSALA, SE / ACCESS Newswire / December 15, 2025 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) - Biovica, a leader in blood-based cancer monitoring, today announced that the compan......

26.11.25 - 09:06	Biovica International: Two New Studies with DiviTum TKa Presented at SABCS 2025 (Accesswire)
	UPPSALA, SE / ACCESS Newswire / November 26, 2025 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) - Biovica, a leader in blood-based cancer monitoring, today announces the presentatio......

23.09.25 - 12:30	Announcement from the Annual General Meeting in Biovica International AB (Accesswire)
	UPPSALA, SE / ACCESS Newswire / September 23, 2025 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) - The annual general meeting of Biovica International AB ("Biovica" or the "Company"......

11.09.25 - 08:30	Biovica International: Biovica Q1 Interim Report May 2025 - July 2025 (Accesswire)
	UPPSALA, SE / ACCESS Newswire / September 11, 2025 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) - Partnership agreement with Tempus and continued organic growth in the USASEK 000sQ......

22.08.25 - 08:30	Notice Of Annual General Meeting in Biovica International AB (Accesswire)
	UPPSALA, SE / ACCESS Newswire / August 22, 2025 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) - The shareholders of Biovica International AB, reg. no. 556774-6150 (the "Company"), a......

13.08.25 - 18:06	Biovica International: Biovica Carries Out a Directed Share Issue of Approximately MSEK 42.2 (Accesswire)
	NOT TO BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH AFRICA, THE UNITED STATES OF ......

05.08.25 - 14:30	Biovica International: Biovica announces outcome of rights issue (Accesswire)
	NOT TO BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH AFRICA, THE UNITED STATES OF ......

25.07.25 - 08:30	Biovica International: Biovica Launches DiviTum TKa for Use in Early Breast Cancer (Accesswire)
	UPPSALA, SE / ACCESS Newswire / July 25, 2025 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) - Biovica, active in blood-based cancer monitoring, today announces the launch of DiviTum......

24.07.25 - 08:30	Biovica International: Biovica Awarded 3 MSEK Contract - 4th from Leading Tier-1 Pharma Company (Accesswire)
	UPPSALA, SE / ACCESS Newswire / July 24, 2025 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) - Biovica, a leader in blood-based cancer monitoring, today announced its fourth's work o......

14.07.25 - 11:30	Announcement from Extra General Meeting in Biovica International AB (Accesswire)
	UPPSALA, SE / ACCESS Newswire / July 14, 2025 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) - Today on 14 July 2025 the extra general meeting of Biovica International AB (the "Compa......

27.06.25 - 08:30	Biovica International AB - Annual Report for the Financial Year 2024/2025 Published (Accesswire)
	UPPSALA, SE / ACCESS Newswire / June 27, 2025 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) - Annual Report for the finacial year 2024/2025 for Biovica International AB is published......

26.06.25 - 08:27	Biovica International: Biovica Granted New European Patent (Accesswire)
	UPPSALA, SE / ACCESS Newswire / June 26, 2025 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) - Biovica today announced that the European Patent Office (EPO) has granted a new patent ......

18.06.25 - 08:30	Biovica International: Year-End Report 2024/2025 (Accesswire)
	UPPSALA, SE / ACCESS Newswire / June 18, 2025 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) - Positive development in the USA continuesSEK tQ424/25Q423/24May-April 24/25May-April 23......

11.06.25 - 10:18	Biovica International: Biovica Signs Agreement with Fifth Tier-1 US Biopharma Company (Accesswire)
	UPPSALA, SE / ACCESS Newswire / June 11, 2025 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) - Biovica, active in blood-based cancer monitoring, has signed a new Master Service Agree......

11.06.25 - 08:42	Notice of Extra General Meeting in Biovica International AB (Accesswire)
	UPPSALA, SE / ACCESS Newswire / June 11, 2025 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) - The shareholders of Biovica International AB, reg. no. 556774-6150 (the "Company"), are......

>weitere News anzeigen...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Notwendigkeit ist bei weitem stärker als die Kunst. - Aischylos

Partner: >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram